Machine Learning Model Can Predict Anti-TNF Drug Response in RA
The model improves anti-TNF drug selection and the effect of genetic markers across multiple cohorts.
Rheumatoid Arthritis
![Comprehensive laboratory evaluation is important if blood transfusion is expected, to screen for antirheumatic drug side effects, and to assess medical comorbidities. [3] The results of these tests should be shared with the surgical team to reduce surgical morbidity and mortality.](https://1fxghyessyy2gaob23ygwzph-wpengine.netdna-ssl.com/wp-content/uploads/sites/18/2019/01/thinkstockphotos454249703101_939914-544x306.jpg)
Neutrophil-Lymphocyte Ratio May Be Used as Disease Activity Marker in Rheumatoid Arthritis
This is the first study to examine the real-world outcome of the management of RA using neutrophil-lymphocyte ratio.
Biomarkers for BMD Changes Differ at Anatomic Sites in Osteoporosis With RA
The study identified biomarkers for changes in bone mineral density at three anatomic sites in patients with osteoporosis secondary to RA.
Rheumatoid Arthritis and Jaw Pain: What Your Patients Need to Know
We examine rheumatoid arthritis and jaw pain: prevalence, symptoms, and tips for your patients to manage their pain.
Boxed Warning Added to Tofacitinib Prescribing Information
The FDA has approved changes to the prescribing information for tofacitinib to include new warnings, including a Boxed Warning, regarding an increased risk of blood clots and death.
Long-Term Safety of Certolizumab Confirmed for RA, axSpA, PsA
Researchers reviewed the long-term certolizumab safety across all its approved indications, including rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis, and Crohn disease.
Higher Response Rate With Filgotinib vs Placebo in Refractory Rheumatoid Arthritis
Among patients with moderately to severely active rheumatoid arthritis (RA) resistant to previous therapy with biologic agents, a significantly higher clinical response rate was seen at 12 weeks for those receiving filgotinib vs placebo.
Increased Risk for Malignancy Found in Rheumatoid Arthritis
Compared with the general population, there is an increased risk for certain cancers in patients with rheumatoid arthritis (RA) in Singapore.
Rheumatoid Arthritis Medications and Sun Exposure: What Your Patients Should Know
Some rheumatoid arthritis medications may cause photosensitivity, or extreme sensitivity to ultraviolet rays from the sun. We list them and offer tips for your patients.
Initial Sustained Remission Common in Rheumatoid Arthritis
Six-month sustained remission (SR) is not uncommon in patients with rheumatoid arthritis.
Next post in Rheumatoid Arthritis
